MCTA
Charming Medical Limited
29.40$
+0.0%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 24 | Q3 24 | Q1 25 | Q3 25 | Q1 26 |
|---|---|---|---|---|---|
| – | +10.1% | -0.4% | +1.9% | +80.9% | |
| – | -9.6% | +1.6% | -13.1% | +179.3% | |
| – | +28.0% | -69.7% | +117.2% | +164.9% | |
| – | +28.0% | +2.6% | – | – | |
| – | -61.7% | -1.5% | -75.9% | +44.3% | |
| – | +21.3% | -21.5% | +49.2% | -35.9% | |
| – | +0.5% | -12.4% | -3.9% | -8.0% | |
| – | -4.8% | -11.6% | +0.9% | -13.2% | |
| – | +10.1% | -10.3% | – | – | |
| – | – | -91.8% | -100.0% | – | |
| – | – | – | +627.0% | +1,347.3% | |
| – | – | – | -61.1% | +108.3% | |
| – | +0.0% | +0.0% | +0.0% | +1.4% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.